- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01734356
Molecular Mechanism Identification in Inherited Arrhythmias and Valvulopathies From Induced Pluripotent Stem Cells (Diag-iPS)
November 6, 2014 updated by: Nantes University Hospital
The recent developments of research on iPS (induced pluripotent stem) cells lead to the establishment of mature cell lines such as cardiomyocytes or valvular interstitial cells with genetic and cellular characteristics of the donors.
These cells represent a biological material more readily available to identify the pathophysiological mechanisms involved in the diseases of BrS or ERS patients, which will lead to the identification of genetic markers.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nantes, France
- Nantes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
22 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- Patient with a family history of inherited arrhythmia or valvulopathy
- Age : 22-60 yo.
- patient no confine to bed
- Male or female
- Written consent
- Patient affiliated to the French social security
Exclusion criteria:
- Pregnant woman
- Patient under 22 yo or adults under guardianship
- Indication against local anesthesia
- Anticoagulant treatment
- Absence or positivity of HIV, HBV, HCV serology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: inherited arrhythmias
6 patient with inherited arrhythmias
|
|
Other: valvulopathies
6 patient with valvulopathies
|
|
Other: controle
8 healthy people for these pathologies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Production of cardiomyocytes modele from skin fibroblast of arrhythmic patient
|
Secondary Outcome Measures
Outcome Measure |
---|
Production of valve interstitial cells modele from skin fibroblast of patient with a valvulopathy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Vincent PROBST, Nantes UH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2011
Primary Completion (Actual)
November 1, 2014
Study Completion (Actual)
November 1, 2014
Study Registration Dates
First Submitted
November 22, 2012
First Submitted That Met QC Criteria
November 22, 2012
First Posted (Estimate)
November 27, 2012
Study Record Updates
Last Update Posted (Estimate)
November 7, 2014
Last Update Submitted That Met QC Criteria
November 6, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BRD/10/11-P
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inherited Arrhythmias and Valvulopathies
-
Children's Hospital of Eastern OntarioHeart and Stroke Foundation of Ontario; Variety Village; City of Toronto Parks...CompletedCardiomyopathy | Congenital Heart Defects | Inherited Cardiac ArrhythmiasCanada
-
University of British ColumbiaQueen's University; Montreal Heart Institute; Quebec Heart InstituteCompletedBrugada Syndrome | Long QT Syndrome | Arrhythmogenic Right Ventricular Cardiomyopathy | Catecholaminergic Polymorphic Ventricular Tachycardia | Inherited Cardiac ArrhythmiasCanada
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceActive, not recruitingPediatric ALL | Long QT Syndrome | Inherited Cardiac Conduction Disorder | Congenital Long Qt SyndromeFrance
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Stichting MetakidsCompletedInherited Metabolic DisordersNetherlands
-
Baylor College of MedicineThe Methodist Hospital Research InstituteTerminatedInherited Metabolic Storage DiseasesUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknownCardiovascular Disease | Blood Coagulation Disorders, Inherited | Atrial Fibrillation | Venous ThrombosesBrazil
-
Medtronic BRCCompletedAtrial Fibrillation | Risk of Cardiac ArrhythmiasNetherlands, Germany, Austria, Belgium, Canada, Czech Republic, Russian Federation, Slovakia
-
National Institute of Allergy and Infectious Diseases...CompletedInherited Immune DeficienciesUnited States
-
Johns Hopkins UniversityNational Human Genome Research Institute (NHGRI)Enrolling by invitationGenetic Counseling | Inherited Cardiac DiseaseUnited States
-
IRCCS Policlinico S. MatteoCompleted
Clinical Trials on Skin biopsies
-
Assistance Publique - Hôpitaux de ParisCompletedIntestinal Epithelial Dysplasia | Tufting EnteropathyFrance
-
Medical University of ViennaRecruiting
-
University Hospital, Strasbourg, FranceCompleted
-
Association pour la Recherche Clinique et ImmunologiqueNot yet recruitingHidradenitis Suppurativa (HS)France
-
Institut de Cancérologie de LorraineCompletedFibrosis | Breast CarcinomaFrance
-
Hospital of South West JutlandOdense University HospitalRecruitingRheumatoid Arthritis | Widespread Chronic Pain | Fibromyalgia, Secondary | Muscle DisorderDenmark
-
University Hospital, LilleGlaxoSmithKlineUnknownSystemic Sclerosis | Systemic SclerodermaFrance
-
Poitiers University HospitalRecruitingImmune Response | Staphylococcus Aureus | Atopic Dermatitis | Cytokines | Bacterial Toxins | T Cells SubsetsFrance
-
Hospices Civils de LyonNot yet recruitingLowry Wood Syndrome | Roifman Syndrome | Taybi Linder Syndrome | Microcephalic Osteodysplastic Primordial Dwarfism Types I and IIIFrance
-
Henry Ford Health SystemM.D. Anderson Cancer CenterCompleted